Affiliated Sites
  • Clinicians Network Payer Bioinformatics
Be The Match

Javascript disabled. This site requires JavaScript How to enable JavaScript.

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close

NMDP

Be The Match
  • About Us
  • E-News Sign Up
  • My Cart
  • Transplant Indications and Outcomes
    • Disease-Specific Indications and Outcomes
      • AML - Adult
      • AML - Pediatric
      • ALL - Adult
      • ALL - Pediatric
      • MDS
      • CML
      • CLL
      • NHL
      • Hodgkin Lymphoma
      • Multiple Myeloma
      • Severe Aplastic Anemia & Marrow Failure
      • Sickle Cell Disease
      • Immune Deficiency Diseases
      • Inherited Metabolic Disorders
      • Thalassemia
      • Other Diseases
    • Additional Outcomes
      • Unrelated vs. Sibling Donor Outcomes
      • Older Patient Outcomes
      • Timing Impact on Outcomes
    • Eligibility
    • Referral Timing Guidelines
    • HLA Today
  • Transplant Therapy and Donor Matching
    • Cell Sources
    • HLA Typing and Matching
    • Donor or Cord Blood Search Process
      • Likelihood of Finding a Match
      • Preliminary Search Request
    • Jason Carter Clinical Trials Program
  • Post-Transplant Care
    • Early Complications
    • Vaccinations
    • Long-Term Care Guidelines
      • Pediatric Considerations
    • Chronic GVHD
      • Skin
      • Nails
      • Scalp and Body Hair
      • Eyes
      • Mouth
      • Lungs
      • Muscles, Fascia, Joints
      • Hematopoietic & Immune
      • GI Tract
      • Liver
      • Genitalia
      • Other
    • Post-Transplant Guidelines
  • Research and News
    • Browse Research
      • Pre-transplant blinatumomab reduces MRD, time to HCT for pediatric patients with B-ALL
      • Novel cytogenetic-based risk scores predict HCT outcomes for patients with CLL
      • Cryopreservation of allogenic HCT grafts does not adversely impact early post-HCT outcomes
      • Precision medicine initiative uses whole genome sequencing to identify novel prognostic signatures and the impact of genomic subgroups in MDS allogeneic HCT patients
    • Browse News
    • About Our Research
    • Transplant Enews
      • Advances in Transplant Enews
      • Resource Connection Enews
  • Resources and Education
    • HCT Presentation Slides
      • Hemaglobinopathies, Transplant Consultation Timing Guidelines
      • Myeloproliferative Neoplasms (MPN), Transplant Consultation Timing Guidelines
    • Patient Resources
    • Financial Resources
    • Materials Catalog
    • Obstetrician Resources
    • Education Catalog
      • Sickle Cell Disease: Exploring treatment options and psychosocial care
      • Continuing Education Discontinuation
      • Building Yourself From The Ground Up
      • Advances in HCT Over Time
    • Technique Video
    • Umbilical Cord Blood Collection Training for Public Donation

  • About Us
  • Email
  • Print This Page

Related Resources

  • Contact Us

Global Transplant Network

Connecting Leading Centers and Partners Worldwide

We are the hub of a global transplant network that facilitates nearly 6,100 transplants each year. Our global network includes more than 500 partners worldwide. The National Marrow Donor Program® (NMDP)/Be The Match® works with this network to facilitate transplants through groundbreaking technology, bioinformatics, search expertise, and unparalleled logistical support at every step to make each transplant possible.

All centers and other organizations in our network must meet our required standards. These standards ensure that donors and patients receive high-quality care and government standards are met.

Donor Centers and Recruitment Centers

Representatives from these recruitment and donor centers support donors through every step of the donation process. These centers are continually monitoring and improving their processes to improve engagement and availability, so donors are available when patients need them. Often, friends and families of patients will ask clinicians how to to host a drive or join the Be The Match Registry®.

Visit BeTheMatch.org to find an upcoming donor drive you your area.

Transplant Centers

We work directly with 180 transplant centers to facilitate unrelated transplants, support patients, provide educational opportunities, and conduct research. Transplant centers in our network must have experienced transplant teams that demonstrate successful patient outcomes with allogeneic transplants. Transplant centers in our network submit outcomes data on all transplants performed through us to our research program, the Center for International Blood and Marrow Transplant Research® (CIBMTR®). Physicians and scientists can access CIBMTR data to use in research studies designed to improve transplant outcomes.

Visit BeTheMatch.org to access a listing of transplant centers. Each center's information includes transplant volume, type of transplant performed, and center-specific outcomes data.

Cord Blood Banks

We have 19 public cord blood banks in our network that work with hospitals across the United States to collect umbilical cord blood for donation and for listing on Be The Match Registry. We partner with these banks to help educate parents on the need for donation and also to facilitate getting the cord blood units to patients in need.

Visit BeTheMatch.org to find a list of hospitals that accept public cord blood donation, and the banks that work with these hospitals.

Collection Centers and Apheresis Centers

We work with more than 150 hospitals and blood centers that perform bone marrow and peripheral blood stem cell (PBSC) collections. As the need for transplants increase, collection and apheresis centers are implementing innovative ways to expand their capacity to serve the growing number of patients in need of a transplant.

Cooperative Registries

We have formal business relationships with 53 donor registries in other countries, known as cooperative registries. Searches through our Be The Match Registry include millions of additional potential donors from these cooperative registries. This means we can provide access to nearly all of the potential donors worldwide. Other countries can access the volunteers listed on our registry in return.

These cooperative agreements are critical in helping patients find matching donors, wherever they may be. Forty-nine percent of the transplants we facilitate involve either a U.S. patient receiving cells from an international donor or an international patient receiving cells from a U.S. donor.

  • Email
  • Print This Page

Slides may be downloaded and used without permission for one-time presentation or personal use.  For publication, use in print or web, or repeated presentations, please submit a Copyright Request Form.

Transplant Indications and Outcomes

  • Disease-Specific Indications and Outcomes
  • Additional Outcomes
  • Eligibility
  • Referral Timing Guidelines
  • HLA Today

Transplant Therapy and Donor Matching

  • Cell Sources
  • HLA Typing and Matching
  • Donor or Cord Blood Search Process
  • Jason Carter Clinical Trials Program

Resources and Education

  • HCT Presentation Slides
  • Patient Resources
  • Financial Resources
  • Materials Catalog
  • Obstetrician Resources
  • Education Catalog
  • Technique Video
  • Umbilical Cord Blood Collection Training for Public Donation

Contact Us

About Us

Our Websites

bethematch.org
BeTheMatch.org Information and support for patients, donors and supporters of our mission.
BeTheMatchBioTherapies.com
BeTheMatchBioTherapies.com Proven solutions for organizations developing and delivering new cellular therapies
CIBMTR.org
CIBMTR.org Transplant research, clinical studies, publications and outcomes data for researchers and clinicians.
National Marrow Donor Program —
Entrusted and under contract to operate the C.W. Bill Young Cell Transplantation Program, including Be The Match Registry®.
Copyright © 1996-2022 National Marrow Donor Program. All Rights Reserved. Terms of Use | Privacy Policy | Trademark & Copyright